SABBY 13G MBRX 2.14.17

Company

Moleculin Biotech, Inc.

Filed

February 14, 2017

Accession Number

0001535610-17-000070

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →